LUNG PROTECTIVE POTENTIAL EFFECT OF ZILEUTON DURING ENDOTOXAEMIA MODEL IN MALE MICE

Zainab Ali Alnfakh1, Rana Talib Al-Nafakh1, Ahmed M Abdul Hameed2

  • 1DEPARTMENT OF PHARMACOLOGY & THERAPEUTICS, FACULTY OF MEDICINE, UNIVERSITY OF KUFA, NAJAF, IRAQ.

Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|February 1, 2023
PubMed
Abstract

Insights

Zileuton demonstrated lung protective effects in a mouse model of polymicrobial sepsis. This drug reduced inflammatory mediators and oxidative stress, mitigating lung injury.

Area of Science:

  • Sepsis research
  • Pulmonary medicine
  • Pharmacology

Background:

  • Polymicrobial sepsis can lead to severe lung injury.
  • Inflammatory and oxidative stress pathways are implicated in sepsis-induced lung damage.

Purpose of the Study:

  • To investigate the lung protective potential of zileuton in polymicrobial sepsis.
  • To assess zileuton's modulation of inflammatory and oxidative stress pathways in the lungs.

Main Methods:

  • Adult male Swiss-albino mice underwent cecal ligation and puncture (CLP) to induce sepsis.
  • Mice were randomized into sham, CLP, vehicle, and zileuton treatment groups.
  • Lung tissues were analyzed for inflammatory cytokines (IL-6, IL-1β, IL-17), leukotrienes (LTB4), HETEs, and oxidative stress markers (F2-isoprostane).

Main Results:

  • Sepsis significantly increased lung inflammatory mediators and oxidative stress markers compared to sham.
  • Zileuton treatment significantly reduced these inflammatory mediators and oxidative stress markers.
  • Histological examination revealed significant lung tissue injury in the sepsis group, which was reduced by zileuton pretreatment.

Conclusions:

  • Zileuton attenuates lung dysfunction in polymicrobial sepsis.
  • The protective effect is mediated by modulating LTB4, 12(S) HETE, and oxidative stress pathways.
  • Zileuton decreases pro-inflammatory cytokine levels (IL-1β, IL-6, IL-17) in sepsis-induced lung injury.

Related Concept Videos